Published in Women's Health Weekly, October 4th, 2007
The paper, Experimental Treatment Of Ovarian Cancers By Adenovirus Vectors Combining Receptor Targeting And Selective Expression Of Tumor Necrosis Factor, authored by GenVec scientist Selva R. Murugesan, Ph.D., appears in the October issue of the International Journal of Oncology, (31: 813-822, 2007). It describes how GenVec technology was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly